United States · FDA National Drug Code directory
Oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-023_4998217b-01c6-d647-e063-6294a90a2ff9
- Product NDC
- 31722-023
- Form
- TABLET, FILM COATED
- Composition / generic term
- Oxcarbazepine
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220111
- Source listing expiry
- 20271231
Source-listed ingredients
- OXCARBAZEPINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (31722-023-01) · 31722-023-01
- 500 TABLET, FILM COATED in 1 BOTTLE (31722-023-05) · 31722-023-05
- 1000 TABLET, FILM COATED in 1 BOTTLE (31722-023-10) · 31722-023-10
- 10 BLISTER PACK in 1 CARTON (31722-023-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 31722-023-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →